Experimental Evolution of Multidrug Resistance in Neurospora crassa under Antifungal Azole Stress

Multidrug resistance, defined as the resistance to multiple drugs in different categories, has been an increasing serious problem. Limited antifungal drugs and the rapid emergence of antifungal resistance prompt a thorough understanding of how the occurrence of multidrug resistance develops and which mechanisms are involved. In this study, experimental evolution was performed under single-azole-drug stress with the model filamentous fungus Neurospora crassa. By about 30 weeks of continuous growth on agar plates containing ketoconazole or voriconazole with weekly transfer, four evolved multidrug-resistant strains 30thK1, 30thK2, 26thV1, and 24thV2 were obtained. Compared to the ancestral strain, all four strains increased resistance not only to commonly used azoles, including ketoconazole, voriconazole, itraconazole, fluconazole, and triadimefon, but also to antifungal drugs in other categories, including terbinafine (allylamine), amorolfine (morpholine), amphotericin B (polyene), polyoxin B (chitin synthesis inhibitor), and carbendazim (β-tubulin inhibitor). After 8 weeks of growth on agar plates without antifungal drugs with weekly transfer, these evolved strains still displayed multidrug-resistant phenotype, suggesting the multidrug resistance could be stably inherited. Transcriptional measurement of drug target genes and drug transporter genes and deletion analysis of the efflux pump gene cdr4 in the evolved strains suggest that overexpression of cdr4 played a major role in the resistance mechanisms for azoles and terbinafine in the evolved strains, particularly for 30thK2 and 26thV1, and evolved drug-resistant strains had less intracellular ketoconazole accumulation and less disruption of ergosterol accumulations under ketoconazole stress compared to wild type. Mutations specifically present in evolved drug-resistant strains were identified by genome re-sequencing, and drug susceptibility test of knockout mutants for most of mutated genes suggests that mutations in 16 genes, functionally novel in drug resistance, potentially contribute to multidrug resistance in evolved strains.

[1]  Daniel A. Charlebois,et al.  Does transcriptional heterogeneity facilitate the development of genetic drug resistance? , 2021, BioEssays : news and reviews in molecular, cellular and developmental biology.

[2]  Chengcheng Hu,et al.  Fungal Zn(II)2Cys6 Transcription Factor ADS-1 Regulates Drug Efflux and Ergosterol Metabolism under Antifungal Azole Stress , 2020, Antimicrobial Agents and Chemotherapy.

[3]  N. Suzuki,et al.  Establishment of Neurospora crassa as a model organism for fungal virology , 2020, Nature Communications.

[4]  T. Gabaldón,et al.  Triazole Evolution of Candida parapsilosis Results in Cross-Resistance to Other Antifungal Drugs, Influences Stress Responses, and Alters Virulence in an Antifungal Drug-Dependent Manner , 2020, mSphere.

[5]  J. Berman,et al.  Drug resistance and tolerance in fungi , 2020, Nature Reviews Microbiology.

[6]  Mark Wilkinson,et al.  Amphibian fungal panzootic causes catastrophic and ongoing loss of biodiversity , 2019, Science.

[7]  Chengcheng Hu,et al.  Transcription factor CCG-8 plays a pivotal role in azole adaptive responses of Neurospora crassa by regulating intracellular azole accumulation , 2019, Current Genetics.

[8]  M. Ghannoum,et al.  Antifungal Resistance: Specific Focus on Multidrug Resistance in Candida auris and Secondary Azole Resistance in Aspergillus fumigatus , 2018, Journal of fungi.

[9]  R. Guthke,et al.  Comparative Genomics of Serial Candida glabrata Isolates and the Rapid Acquisition of Echinocandin Resistance during Therapy , 2018, Antimicrobial Agents and Chemotherapy.

[10]  L. Cowen,et al.  Antifungal drug resistance: evolution, mechanisms and impact. , 2018, Current opinion in microbiology.

[11]  Erratum. , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  M. Fisher,et al.  Worldwide emergence of resistance to antifungal drugs challenges human health and food security , 2018, Science.

[13]  C. Lass‐Flörl,et al.  Aspergillus terreus: Novel lessons learned on amphotericin B resistance. , 2018, Medical mycology.

[14]  Chengcheng Hu,et al.  Abnormal Ergosterol Biosynthesis Activates Transcriptional Responses to Antifungal Azoles , 2018, Front. Microbiol..

[15]  H. Kamata,et al.  Resistance Mechanism in a Terbinafine-Resistant Strain of Microsporum canis , 2018, Mycopathologia.

[16]  M. Milewska,et al.  Transport Deficiency Is the Molecular Basis of Candida albicans Resistance to Antifungal Oligopeptides , 2017, Frontiers in Microbiology.

[17]  S. Sarrocco,et al.  Preharvest application of beneficial fungi as a strategy to prevent postharvest mycotoxin contamination: A review , 2017, Crop Protection.

[18]  M. Arendrup,et al.  Multidrug-Resistant Candida: Epidemiology, Molecular Mechanisms, and Treatment , 2017, The Journal of infectious diseases.

[19]  J. Berman,et al.  Multidrug-Resistant Candida haemulonii and C. auris, Tel Aviv, Israel , 2017, Emerging infectious diseases.

[20]  Christina A. Cuomo,et al.  Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  A. Chowdhary,et al.  Clinical implications of globally emerging azole resistance in Aspergillus fumigatus , 2016, Philosophical Transactions of the Royal Society B: Biological Sciences.

[22]  Ling Lu,et al.  Screening and Characterization of a Non-cyp51A Mutation in an Aspergillus fumigatus cox10 Strain Conferring Azole Resistance , 2016, Antimicrobial Agents and Chemotherapy.

[23]  Eric D. Kelsic,et al.  Spatiotemporal microbial evolution on antibiotic landscapes , 2016, Science.

[24]  G. I. Lang,et al.  Experimental evolution in fungi: An untapped resource. , 2016, Fungal genetics and biology : FG & B.

[25]  Hongju Ma,et al.  Carbendazim resistance in field isolates of Sclerotinia sclerotiorum in China and its management , 2016 .

[26]  X. Chen,et al.  De-repression of CSP-1 activates adaptive responses to antifungal azoles , 2016, Scientific Reports.

[27]  Yitzhak Pilpel,et al.  A Relay Race on the Evolutionary Adaptation Spectrum , 2015, Cell.

[28]  Diarmaid Hughes,et al.  Evolutionary consequences of drug resistance: shared principles across diverse targets and organisms , 2015, Nature Reviews Genetics.

[29]  Cheng Jin,et al.  Transcription Factor ADS-4 Regulates Adaptive Responses and Resistance to Antifungal Azole Stress , 2015, Antimicrobial Agents and Chemotherapy.

[30]  Shaojie Li,et al.  Sterol C-22 Desaturase ERG5 Mediates the Sensitivity to Antifungal Azoles in Neurospora crassa and Fusarium verticillioides , 2013, Front. Microbiol..

[31]  E. Mellado,et al.  Ergosterol biosynthesis in Aspergillus fumigatus: its relevance as an antifungal target and role in antifungal drug resistance , 2013, Front. Microbio..

[32]  Chengcheng Hu,et al.  CDR4 is the major contributor to azole resistance among four Pdr5p-like ABC transporters in Neurospora crassa. , 2012, Fungal biology.

[33]  J. Brownstein,et al.  Emerging fungal threats to animal, plant and ecosystem health , 2012, Nature.

[34]  S. Ying,et al.  High resistance of Isaria fumosorosea to carbendazim arises from the overexpression of an ATP‐binding cassette transporter (ifT1) rather than tubulin mutation , 2012, Journal of applied microbiology.

[35]  M. Fisher,et al.  The rise and rise of emerging infectious fungi challenges food security and ecosystem health , 2011 .

[36]  L. Cowen,et al.  Regulatory Circuitry Governing Fungal Development, Drug Resistance, and Disease , 2011, Microbiology and Molecular Reviews.

[37]  Ming-guo Zhou,et al.  Characterization of Fusarium graminearum isolates resistant to both carbendazim and a new fungicide JS399-19. , 2009, Phytopathology.

[38]  Kailash Gulshan,et al.  Multidrug Resistance in Fungi , 2007, Eukaryotic Cell.

[39]  W. Maccheroni,et al.  Role of the ABC transporter TruMDR2 in terbinafine, 4-nitroquinoline N-oxide and ethidium bromide susceptibility in Trichophyton rubrum. , 2006, Journal of medical microbiology.

[40]  J. Heitman,et al.  Disruption of Ergosterol Biosynthesis Confers Resistance to Amphotericin B in Candida lusitaniae , 2003, Antimicrobial Agents and Chemotherapy.

[41]  C. Selitrennikoff,et al.  Neurospora crassa FKS Protein Binds to the (1,3)β-Glucan Synthase Substrate, UDP-Glucose , 2003, Current Microbiology.

[42]  John W. Taylor,et al.  The fitness of filamentous fungi. , 2002, Trends in microbiology.

[43]  T. Hibi,et al.  Functional Analysis of an ATP-Binding Cassette Transporter Gene in Botrytis cinerea by Gene Disruption , 2001, Journal of General Plant Pathology.

[44]  L. Cowen,et al.  Evolution of Drug Resistance in Experimental Populations of Candida albicans , 2000, Journal of bacteriology.

[45]  E. Selker,et al.  Improved plasmids for gene targeting at the his-3 locus of Neurospora crassa by electroporation , 1997 .

[46]  H. Inoue,et al.  A single amino-acid substitution in the beta-tubulin gene of Neurospora confers both carbendazim resistance and diethofencarb sensitivity , 1992, Current Genetics.

[47]  K. Isono,et al.  Nucleoside antibiotics: structure, biological activity, and biosynthesis. , 1988, The Journal of antibiotics.

[48]  W. Kingsbury,et al.  Anti-Candida activity of polyoxin: example of peptide transport in yeasts , 1984, Antimicrobial Agents and Chemotherapy.

[49]  M. B. Davies.  Peptide uptake in Candida albicans. , 1980, Journal of general microbiology.

[50]  K. Isono,et al.  Studies on polyoxins, antifungal antibiotics. 13. The structure of polyoxins. , 1969, Journal of the American Chemical Society.

[51]  K. Isono,et al.  A NEW ANTIBIOTIC, POLYOXIN A. , 1965, The Journal of antibiotics.

[52]  J. Adrio,et al.  Antifungals , 2017, Reactions Weekly.

[53]  K. Lewis.  Multidrug tolerance of biofilms and persister cells. , 2008, Current topics in microbiology and immunology.

[54]  John W. Taylor,et al.  A rapid, high yield mini-prep method for isolation of total genomic DNA from fungi. , 1988 .

[55]  T. Hasegawa,et al.  NEW antibiotic. , 1953, Southern medical journal.